Westfield Capital Management Company »

Legend Biotech 2 Adr Rep Ord shares owned by Westfield Capital Management Company

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Westfield Capital Management Company from 13F filings

Historical chart of Westfield Capital Management Company investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Westfield Capital Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Westfield Capital Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $107M 1.8M 60.17
2023-09-30 $112M 1.7M 67.17
2023-06-30 $67M 972k 69.03

More positions owned by Westfield Capital Management Company

Microsoft Corporation (MSFT)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
TransDigm Group Incorporated (TDG)
NVIDIA Corporation (NVDA)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
Builders FirstSource (BLDR)
Dex (DXCM)
UnitedHealth (UNH)
Servicenow (NOW)
Axon Enterprise (AXON)
Saia (SAIA)

View all positions for Westfield Capital Management Company

Top funds holding Legend Biotech 2 Adr Rep Ord

T. Rowe Price Associates
RA Capital Management
Hillhouse Capital Advisors
Wellington Management Company
Massachusetts Financial Services
Paradigm Biocapital Advisors
Henderson Group
Westfield Capital Management Company
Holocene Advisors
Federated Investors
Alliancebernstein
TimesSquare Capital Management
Arrowpoint Asset Management
Matthews International Capital Management
Avidity Partners Management

View all funds holding Legend Biotech 2 Adr Rep Ord